Collagen content determines 98% of skin health and youthfulness
The aging process of human beings is a complex biological process, in which the most intuitive change is the loss of collagen. Collagen plays an important role in the human body, and the content of collagen determines 98% of skin health and youthfulness.
In the skin, the two main types of collagen are type I collagen and type III collagen. In infancy, the ratio of type III collagen to type I collagen is about 1:1, which makes the skin of infants and young children have excellent elasticity and repair functions. However, with age, the type III collagen in adult skin will gradually be lost, and the ratio of type I collagen to type III collagen is 7:3.
If the collagen in the skin is compared to a Simmons bed, then type I collagen is like a spring, providing support for the skin; while type III collagen is like a mesh-like interwoven content, providing filling for the skin. When type III collagen is lost, it will not only cause the skin to become thinner, looser, and sagging, but also cause the appearance of chloasma. At the same time, the dermis of adults does not have the function of actively synthesizing type III collagen, and can only synthesize type I collagen. Especially after the age of 25, the synthesis rate of type III collagen in the skin cannot keep up with the loss rate, which eventually leads to wrinkles, sagging and other aging phenomena. Supplementing type III collagen is an inevitable choice to fight against natural skin aging. Yaohai Novagen Bio independently develops recombinant type III humanized collagen Yaohai Novagen Bio uses the recombinant protein pharmaceutical technology platform of its parent company Yaohai Bio and synthetic biology to successfully develop recombinant type III humanized collagen: it is consistent with the gene sequence of type III collagen in the human body, and the raw material is 100% humanized, has strong biocompatibility, high purity, low endotoxin and low sensitization rate.
The core advantages of Yaohai Novagen Biological's recombinant collagen
Yaohai Novagen Biological's recombinant type III collagen has an independent core patent: the amino acid sequence designed theoretically is exactly the same as the sequence of the actual raw material, with a total chain length of 410 amino acids, and no repeated splicing: it includes hydrophilic fragments, high-activity fragments and triple-helix fragments. The molecular weight is 36kD, which is easier to absorb as a raw material for medical devices.
Another advantage of Yaohai Novagen Biorecombinant Type III Humanized Collagen is its safety and effectiveness. With the help of Yaohai Bio's recombinant protein development process platform (molecular construction platform - fermentation process platform - purification preparation platform - quality research platform), recombinant type III humanized collagen is constructed, and then the filling production (packaging material sterilization - product sterilization - aseptic filling and freeze-drying) is completed through the B+A clean workshop of the drug. The raw materials of medical devices are prepared according to the standards of making drugs to ensure the safety of raw materials from the source.
